While most measurements were obtained within approximately two months of either HIV/AIDS or fungal infection diagnosis, the lack of a strictly standardized schedule means that CD4+ levels may still have varied due to treatment response or disease progression, potentially leading to a misclassification of patients’ immune statuses. The gene discussed is CD4; the disease is fungal infectious disease.